

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.63270566 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.63270566 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.38124841 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.38124841 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.92538085 |
| 6 | complement activation, alternative pathway (GO:0006957) | 5.58957790 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.52573976 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.47628138 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.34779408 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.34779408 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.34779408 |
| 12 | glyoxylate metabolic process (GO:0046487) | 5.33586965 |
| 13 | regulation of protein activation cascade (GO:2000257) | 5.31677719 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.30071175 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 5.26635734 |
| 16 | bile acid biosynthetic process (GO:0006699) | 5.24607351 |
| 17 | cysteine metabolic process (GO:0006534) | 5.21269635 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.13676749 |
| 19 | urea metabolic process (GO:0019627) | 5.07138467 |
| 20 | urea cycle (GO:0000050) | 5.07138467 |
| 21 | regulation of complement activation (GO:0030449) | 5.05824155 |
| 22 | tryptophan metabolic process (GO:0006568) | 5.04834633 |
| 23 | protein carboxylation (GO:0018214) | 5.04383354 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.04383354 |
| 25 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.96995995 |
| 26 | regulation of fibrinolysis (GO:0051917) | 4.92112901 |
| 27 | high-density lipoprotein particle remodeling (GO:0034375) | 4.72584735 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.65976577 |
| 29 | lysine metabolic process (GO:0006553) | 4.65798906 |
| 30 | lysine catabolic process (GO:0006554) | 4.65798906 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.61031709 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.57245668 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.54884412 |
| 34 | bile acid metabolic process (GO:0008206) | 4.51374930 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 4.40304861 |
| 36 | triglyceride homeostasis (GO:0070328) | 4.38110759 |
| 37 | acylglycerol homeostasis (GO:0055090) | 4.38110759 |
| 38 | plasma lipoprotein particle clearance (GO:0034381) | 4.37451181 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.29059293 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.25424865 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.16550104 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.13877664 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.13877664 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.13877664 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.12581557 |
| 46 | exogenous drug catabolic process (GO:0042738) | 4.12321857 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.03817073 |
| 48 | ethanol oxidation (GO:0006069) | 3.98067627 |
| 49 | phospholipid efflux (GO:0033700) | 3.97410888 |
| 50 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.87892200 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 3.86637806 |
| 52 | negative regulation of sterol transport (GO:0032372) | 3.86637806 |
| 53 | bile acid and bile salt transport (GO:0015721) | 3.86554228 |
| 54 | cellular amino acid catabolic process (GO:0009063) | 3.85656322 |
| 55 | phospholipid homeostasis (GO:0055091) | 3.82914412 |
| 56 | cellular modified amino acid catabolic process (GO:0042219) | 3.81893923 |
| 57 | coenzyme catabolic process (GO:0009109) | 3.81867718 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 3.81033620 |
| 59 | fibrinolysis (GO:0042730) | 3.79316160 |
| 60 | acetyl-CoA metabolic process (GO:0006084) | 3.77610505 |
| 61 | valine metabolic process (GO:0006573) | 3.76979448 |
| 62 | regulation of cholesterol homeostasis (GO:2000188) | 3.76817238 |
| 63 | glycine metabolic process (GO:0006544) | 3.76480256 |
| 64 | positive regulation of lipid catabolic process (GO:0050996) | 3.76422713 |
| 65 | fatty acid beta-oxidation (GO:0006635) | 3.75912970 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 3.75487359 |
| 67 | glutamate metabolic process (GO:0006536) | 3.72518892 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 3.71860461 |
| 69 | cellular glucuronidation (GO:0052695) | 3.70680548 |
| 70 | complement activation (GO:0006956) | 3.70352442 |
| 71 | fatty acid oxidation (GO:0019395) | 3.69846812 |
| 72 | complement activation, classical pathway (GO:0006958) | 3.66581226 |
| 73 | benzene-containing compound metabolic process (GO:0042537) | 3.65455517 |
| 74 | cholesterol efflux (GO:0033344) | 3.65446794 |
| 75 | 2-oxoglutarate metabolic process (GO:0006103) | 3.64777706 |
| 76 | lipid oxidation (GO:0034440) | 3.62322765 |
| 77 | cytolysis (GO:0019835) | 3.61338393 |
| 78 | cellular biogenic amine catabolic process (GO:0042402) | 3.57230514 |
| 79 | amine catabolic process (GO:0009310) | 3.57230514 |
| 80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.54910687 |
| 81 | protein activation cascade (GO:0072376) | 3.53982502 |
| 82 | imidazole-containing compound metabolic process (GO:0052803) | 3.53633155 |
| 83 | plasma lipoprotein particle assembly (GO:0034377) | 3.53396423 |
| 84 | short-chain fatty acid metabolic process (GO:0046459) | 3.53355476 |
| 85 | fatty acid catabolic process (GO:0009062) | 3.52530639 |
| 86 | negative regulation of lipase activity (GO:0060192) | 3.51594063 |
| 87 | carboxylic acid catabolic process (GO:0046395) | 3.51591358 |
| 88 | organic acid catabolic process (GO:0016054) | 3.51591358 |
| 89 | drug catabolic process (GO:0042737) | 3.49533897 |
| 90 | cholesterol homeostasis (GO:0042632) | 3.49446848 |
| 91 | monocarboxylic acid catabolic process (GO:0072329) | 3.48499776 |
| 92 | low-density lipoprotein particle clearance (GO:0034383) | 3.48129909 |
| 93 | epoxygenase P450 pathway (GO:0019373) | 3.46473838 |
| 94 | sterol homeostasis (GO:0055092) | 3.45451593 |
| 95 | aldehyde catabolic process (GO:0046185) | 3.43977755 |
| 96 | negative regulation of protein activation cascade (GO:2000258) | 3.42911906 |
| 97 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.41627288 |
| 98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.41627288 |
| 99 | opsonization (GO:0008228) | 3.41586437 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 3.41122698 |
| 101 | drug transmembrane transport (GO:0006855) | 3.40779570 |
| 102 | regulation of apoptotic cell clearance (GO:2000425) | 3.39283222 |
| 103 | omega-hydroxylase P450 pathway (GO:0097267) | 3.36589617 |
| 104 | regulation of plasminogen activation (GO:0010755) | 3.10623990 |
| 105 | positive regulation of extracellular matrix organization (GO:1903055) | 3.06349428 |
| 106 | negative regulation of complement activation (GO:0045916) | 2.96280322 |
| 107 | negative regulation of fatty acid transport (GO:2000192) | 2.90954158 |
| 108 | acute-phase response (GO:0006953) | 2.85798580 |
| 109 | ethanol metabolic process (GO:0006067) | 2.82327804 |
| 110 | negative regulation of blood coagulation (GO:0030195) | 2.81329836 |
| 111 | negative regulation of hemostasis (GO:1900047) | 2.81329836 |
| 112 | regulation of humoral immune response (GO:0002920) | 2.79580074 |
| 113 | mannose metabolic process (GO:0006013) | 2.77533078 |
| 114 | blood coagulation, intrinsic pathway (GO:0007597) | 2.66016196 |
| 115 | negative regulation of humoral immune response (GO:0002921) | 2.60503503 |
| 116 | negative regulation of coagulation (GO:0050819) | 2.59817178 |
| 117 | positive regulation of blood coagulation (GO:0030194) | 2.53585206 |
| 118 | positive regulation of hemostasis (GO:1900048) | 2.53585206 |
| 119 | negative regulation of wound healing (GO:0061045) | 2.50808531 |
| 120 | virion attachment to host cell (GO:0019062) | 2.47730488 |
| 121 | adhesion of symbiont to host cell (GO:0044650) | 2.47730488 |
| 122 | response to mercury ion (GO:0046689) | 2.46918316 |
| 123 | regulation of extracellular matrix disassembly (GO:0010715) | 2.46075338 |
| 124 | adhesion of symbiont to host (GO:0044406) | 2.45765892 |
| 125 | drug metabolic process (GO:0017144) | 2.45072702 |
| 126 | basement membrane organization (GO:0071711) | 2.42392723 |
| 127 | positive regulation of coagulation (GO:0050820) | 2.39524706 |
| 128 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.38137188 |
| 129 | regulation of extracellular matrix organization (GO:1903053) | 2.35624124 |
| 130 | negative regulation of lipid transport (GO:0032369) | 2.34220220 |
| 131 | hormone catabolic process (GO:0042447) | 2.32441079 |
| 132 | detection of molecule of bacterial origin (GO:0032490) | 2.30783202 |
| 133 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.27910234 |
| 134 | glucuronate metabolic process (GO:0019585) | 2.26197334 |
| 135 | uronic acid metabolic process (GO:0006063) | 2.26197334 |
| 136 | barbed-end actin filament capping (GO:0051016) | 2.23796252 |
| 137 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.23369230 |
| 138 | macroautophagy (GO:0016236) | 2.22854033 |
| 139 | skin morphogenesis (GO:0043589) | 2.22299425 |
| 140 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.18598082 |
| 141 | positive regulation of cholesterol efflux (GO:0010875) | 2.17949554 |
| 142 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.17732415 |
| 143 | lipoprotein metabolic process (GO:0042157) | 2.17563669 |
| 144 | cell migration involved in heart development (GO:0060973) | 2.16905079 |
| 145 | apoptotic cell clearance (GO:0043277) | 2.16482283 |
| 146 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.14025446 |
| 147 | growth hormone receptor signaling pathway (GO:0060396) | 2.13119326 |
| 148 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.12531704 |
| 149 | detection of external biotic stimulus (GO:0098581) | 2.12390372 |
| 150 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.11118502 |
| 151 | positive regulation of cholesterol transport (GO:0032376) | 2.10095979 |
| 152 | positive regulation of sterol transport (GO:0032373) | 2.10095979 |
| 153 | endodermal cell differentiation (GO:0035987) | 2.09876840 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.51064924 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.51724264 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.32414768 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.95894096 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.74290888 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.68403907 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.21710297 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.87382106 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.28220299 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.82612560 |
| 11 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.53490554 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5614379 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95635416 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86222726 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 1.85350079 |
| 16 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.83664975 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.83087614 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73301303 |
| 19 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.70815576 |
| 20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65762723 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.65571831 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.49031360 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40834954 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39167232 |
| 25 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38407517 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36759054 |
| 27 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.32711626 |
| 28 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.30109588 |
| 29 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29965332 |
| 30 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26611216 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.26512120 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.24878659 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24814436 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.24409224 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24036253 |
| 36 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.23790448 |
| 37 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21862943 |
| 38 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18792760 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15971119 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15827191 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15682909 |
| 42 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15349479 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14693622 |
| 44 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14372607 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14012287 |
| 46 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.12796500 |
| 47 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11602756 |
| 48 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10873946 |
| 49 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.10284701 |
| 50 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09601188 |
| 51 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.09022552 |
| 52 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08621391 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08315660 |
| 54 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06786886 |
| 55 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05923822 |
| 56 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05574106 |
| 57 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04507271 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02779611 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01050094 |
| 60 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00790747 |
| 61 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00174897 |
| 62 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.00084608 |
| 63 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99131324 |
| 64 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98837710 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98581662 |
| 66 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98503749 |
| 67 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.98237792 |
| 68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97814539 |
| 69 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97565056 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97497356 |
| 71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97088385 |
| 72 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97032846 |
| 73 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95716321 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95432755 |
| 75 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93869717 |
| 76 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.90988421 |
| 77 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88271080 |
| 78 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.87620037 |
| 79 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87480120 |
| 80 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87182318 |
| 81 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86866888 |
| 82 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86525966 |
| 83 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.85845948 |
| 84 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.85709288 |
| 85 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85469932 |
| 86 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85394308 |
| 87 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.84582176 |
| 88 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.83099104 |
| 89 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.82765943 |
| 90 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.82542957 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82268622 |
| 92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82268622 |
| 93 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.82253814 |
| 94 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82067677 |
| 95 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81723187 |
| 96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79936635 |
| 97 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.76698885 |
| 98 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76407459 |
| 99 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.75524793 |
| 100 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.75073543 |
| 101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73626393 |
| 102 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.72635327 |
| 103 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.72635327 |
| 104 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70382836 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.70312079 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.69504538 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.69328339 |
| 108 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.69315794 |
| 109 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.69301335 |
| 110 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.68174024 |
| 111 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66747675 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65645202 |
| 113 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.65177014 |
| 114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63308680 |
| 115 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.63112433 |
| 116 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.63002847 |
| 117 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62493682 |
| 118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62461057 |
| 119 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.61998310 |
| 120 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.61482512 |
| 121 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.61273683 |
| 122 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60130976 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59347279 |
| 124 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58118995 |
| 125 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57996165 |
| 126 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57137362 |
| 127 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.56104714 |
| 128 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.55563645 |
| 129 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.54608663 |
| 130 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.54560349 |
| 131 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53306709 |
| 132 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.53211409 |
| 133 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.52962465 |
| 134 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.52461834 |
| 135 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52333588 |
| 136 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.52171605 |
| 137 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.51351680 |
| 138 | CJUN_26792858_Chip-Seq_BT549_Human | 0.51132089 |
| 139 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.49898546 |
| 140 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.49813819 |
| 141 | ATF3_27146783_Chip-Seq_COLON_Human | 0.49756089 |
| 142 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.49227718 |
| 143 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.48763241 |
| 144 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.48523647 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.26842686 |
| 2 | MP0005360_urolithiasis | 6.72108797 |
| 3 | MP0005365_abnormal_bile_salt | 5.52803300 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.42336264 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.41625285 |
| 6 | MP0003252_abnormal_bile_duct | 3.71117446 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.49755214 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.40086364 |
| 9 | MP0009840_abnormal_foam_cell | 2.92969830 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.79890508 |
| 11 | MP0005083_abnormal_biliary_tract | 2.70728903 |
| 12 | MP0005332_abnormal_amino_acid | 2.62616270 |
| 13 | MP0003279_aneurysm | 2.49539584 |
| 14 | MP0003195_calcinosis | 2.41188103 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.30364023 |
| 16 | MP0005503_abnormal_tendon_morphology | 2.21381474 |
| 17 | MP0000751_myopathy | 2.20841822 |
| 18 | MP0000609_abnormal_liver_physiology | 2.15931990 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.13812392 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.11969374 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.05595460 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.01031305 |
| 23 | MP0005670_abnormal_white_adipose | 1.98668834 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.80484222 |
| 25 | MP0003091_abnormal_cell_migration | 1.58025083 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.57326426 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.51846967 |
| 28 | MP0003868_abnormal_feces_composition | 1.47351088 |
| 29 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.44031192 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.43119456 |
| 31 | MP0004130_abnormal_muscle_cell | 1.40895117 |
| 32 | MP0002933_joint_inflammation | 1.40096158 |
| 33 | MP0000767_abnormal_smooth_muscle | 1.38944183 |
| 34 | MP0001764_abnormal_homeostasis | 1.37943898 |
| 35 | MP0003303_peritoneal_inflammation | 1.35734456 |
| 36 | MP0003186_abnormal_redox_activity | 1.34018989 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.32900263 |
| 38 | MP0004510_myositis | 1.29490720 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.28313694 |
| 40 | MP0010368_abnormal_lymphatic_system | 1.28229914 |
| 41 | MP0005409_darkened_coat_color | 1.21825517 |
| 42 | MP0003011_delayed_dark_adaptation | 1.21309155 |
| 43 | MP0000598_abnormal_liver_morphology | 1.19953864 |
| 44 | MP0004858_abnormal_nervous_system | 1.18242433 |
| 45 | MP0002254_reproductive_system_inflammat | 1.17138453 |
| 46 | MP0002108_abnormal_muscle_morphology | 1.16368555 |
| 47 | MP0003045_fibrosis | 1.16131302 |
| 48 | MP0000685_abnormal_immune_system | 1.16066534 |
| 49 | MP0003828_pulmonary_edema | 1.15934676 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.12002509 |
| 51 | MP0002971_abnormal_brown_adipose | 1.10011574 |
| 52 | MP0009764_decreased_sensitivity_to | 1.09688342 |
| 53 | MP0006054_spinal_hemorrhage | 1.09211473 |
| 54 | MP0002896_abnormal_bone_mineralization | 1.05564194 |
| 55 | MP0000604_amyloidosis | 1.05302705 |
| 56 | MP0009763_increased_sensitivity_to | 1.03485908 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.02332241 |
| 58 | MP0002419_abnormal_innate_immunity | 1.02287278 |
| 59 | MP0005647_abnormal_sex_gland | 1.02224866 |
| 60 | MP0005451_abnormal_body_composition | 1.01447616 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 0.99039137 |
| 62 | MP0004036_abnormal_muscle_relaxation | 0.96707006 |
| 63 | MP0005334_abnormal_fat_pad | 0.95643644 |
| 64 | MP0001790_abnormal_immune_system | 0.95193979 |
| 65 | MP0005387_immune_system_phenotype | 0.95193979 |
| 66 | MP0004947_skin_inflammation | 0.94763802 |
| 67 | MP0005595_abnormal_vascular_smooth | 0.94582456 |
| 68 | MP0004087_abnormal_muscle_fiber | 0.94147714 |
| 69 | MP0002876_abnormal_thyroid_physiology | 0.93547476 |
| 70 | MP0001661_extended_life_span | 0.93483483 |
| 71 | MP0001756_abnormal_urination | 0.93295271 |
| 72 | MP0006138_congestive_heart_failure | 0.93024668 |
| 73 | MP0009697_abnormal_copulation | 0.92946104 |
| 74 | MP0008469_abnormal_protein_level | 0.92672816 |
| 75 | MP0005390_skeleton_phenotype | 0.91881950 |
| 76 | MP0008004_abnormal_stomach_pH | 0.91527658 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 0.90106110 |
| 78 | MP0000749_muscle_degeneration | 0.89437914 |
| 79 | MP0003724_increased_susceptibility_to | 0.89361214 |
| 80 | MP0000733_abnormal_muscle_development | 0.88781895 |
| 81 | MP0005275_abnormal_skin_tensile | 0.88609145 |
| 82 | MP0000759_abnormal_skeletal_muscle | 0.87401561 |
| 83 | MP0009780_abnormal_chondrocyte_physiolo | 0.87100314 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 0.86856813 |
| 85 | MP0005025_abnormal_response_to | 0.86184956 |
| 86 | * MP0009642_abnormal_blood_homeostasis | 0.84010203 |
| 87 | MP0000747_muscle_weakness | 0.83578770 |
| 88 | MP0009785_altered_susceptibility_to | 0.83016882 |
| 89 | MP0002078_abnormal_glucose_homeostasis | 0.82908207 |
| 90 | MP0000013_abnormal_adipose_tissue | 0.82186847 |
| 91 | MP0005220_abnormal_exocrine_pancreas | 0.82141196 |
| 92 | MP0005058_abnormal_lysosome_morphology | 0.82065865 |
| 93 | MP0005076_abnormal_cell_differentiation | 0.81789511 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.81737308 |
| 95 | MP0003300_gastrointestinal_ulcer | 0.81567124 |
| 96 | MP0005508_abnormal_skeleton_morphology | 0.80935172 |
| 97 | MP0001851_eye_inflammation | 0.80637706 |
| 98 | MP0000858_altered_metastatic_potential | 0.80583672 |
| 99 | MP0001542_abnormal_bone_strength | 0.80384093 |
| 100 | MP0005330_cardiomyopathy | 0.78284443 |
| 101 | MP0009384_cardiac_valve_regurgitation | 0.77968139 |
| 102 | MP0001849_ear_inflammation | 0.77752208 |
| 103 | MP0005375_adipose_tissue_phenotype | 0.77733960 |
| 104 | MP0001915_intracranial_hemorrhage | 0.77222664 |
| 105 | MP0006082_CNS_inflammation | 0.76953164 |
| 106 | MP0009115_abnormal_fat_cell | 0.76887292 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.76726897 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.76703640 |
| 109 | MP0010155_abnormal_intestine_physiology | 0.75297961 |
| 110 | MP0002332_abnormal_exercise_endurance | 0.75176845 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.74105354 |
| 112 | MP0002106_abnormal_muscle_physiology | 0.73681334 |
| 113 | MP0006036_abnormal_mitochondrial_physio | 0.71643469 |
| 114 | MP0005535_abnormal_body_temperature | 0.71167257 |
| 115 | MP0005376_homeostasis/metabolism_phenot | 0.70825563 |
| 116 | MP0004782_abnormal_surfactant_physiolog | 0.69548365 |
| 117 | MP0003436_decreased_susceptibility_to | 0.69360974 |
| 118 | MP0003690_abnormal_glial_cell | 0.67451213 |
| 119 | MP0005408_hypopigmentation | 0.65073660 |
| 120 | MP0002060_abnormal_skin_morphology | 0.65029476 |
| 121 | MP0002168_other_aberrant_phenotype | 0.64285766 |
| 122 | MP0002928_abnormal_bile_duct | 0.63444577 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.63176997 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.62636846 |
| 125 | MP0005023_abnormal_wound_healing | 0.61723333 |
| 126 | MP0005448_abnormal_energy_balance | 0.60618144 |
| 127 | MP0002970_abnormal_white_adipose | 0.58950996 |
| 128 | MP0009053_abnormal_anal_canal | 0.57170240 |
| 129 | MP0000249_abnormal_blood_vessel | 0.55825185 |
| 130 | MP0003566_abnormal_cell_adhesion | 0.54356220 |
| 131 | MP0002796_impaired_skin_barrier | 0.54177228 |
| 132 | MP0002295_abnormal_pulmonary_circulatio | 0.53899003 |
| 133 | MP0004272_abnormal_basement_membrane | 0.53321648 |
| 134 | MP0005164_abnormal_response_to | 0.53278502 |
| 135 | MP0010234_abnormal_vibrissa_follicle | 0.52123757 |
| 136 | MP0001958_emphysema | 0.50820196 |
| 137 | MP0003329_amyloid_beta_deposits | 0.50059105 |
| 138 | MP0001881_abnormal_mammary_gland | 0.48462619 |
| 139 | MP0005395_other_phenotype | 0.48057237 |
| 140 | MP0003075_altered_response_to | 0.47340498 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.46428355 |
| 142 | MP0005266_abnormal_metabolism | 0.46291165 |
| 143 | MP0003959_abnormal_lean_body | 0.45751880 |
| 144 | MP0004883_abnormal_blood_vessel | 0.45695372 |
| 145 | MP0005166_decreased_susceptibility_to | 0.45691569 |
| 146 | MP0002135_abnormal_kidney_morphology | 0.45497900 |
| 147 | MP0001243_abnormal_dermal_layer | 0.43080796 |
| 148 | MP0005167_abnormal_blood-brain_barrier | 0.42383336 |
| 149 | MP0001765_abnormal_ion_homeostasis | 0.42275545 |
| 150 | MP0001533_abnormal_skeleton_physiology | 0.40350393 |
| 151 | MP0001845_abnormal_inflammatory_respons | 0.40097413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.83082932 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.35651196 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.15991836 |
| 4 | Xanthomatosis (HP:0000991) | 5.87658052 |
| 5 | Complement deficiency (HP:0004431) | 5.86571289 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.68399297 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.44835984 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.20651415 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.93176797 |
| 10 | Protrusio acetabuli (HP:0003179) | 4.39098392 |
| 11 | Abnormality of complement system (HP:0005339) | 4.35659906 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.31459898 |
| 13 | Joint hemorrhage (HP:0005261) | 4.29855879 |
| 14 | Hyperammonemia (HP:0001987) | 4.29185755 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.26790065 |
| 16 | Epidermoid cyst (HP:0200040) | 4.18543431 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12929059 |
| 18 | Ketosis (HP:0001946) | 4.12134169 |
| 19 | Hyperglycinuria (HP:0003108) | 4.08991967 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.04842677 |
| 21 | Hyperglycinemia (HP:0002154) | 3.99601351 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.99409265 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.89588735 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 3.89588735 |
| 25 | Hypoglycemic coma (HP:0001325) | 3.85915258 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.71261094 |
| 27 | Type 1 muscle fiber predominance (HP:0003803) | 3.66257927 |
| 28 | Premature rupture of membranes (HP:0001788) | 3.62245669 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.57141023 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.56923535 |
| 31 | Fat malabsorption (HP:0002630) | 3.56139957 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.44473451 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 3.38792772 |
| 34 | Aortic aneurysm (HP:0004942) | 3.36214306 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.34339642 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 3.34093980 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.26882882 |
| 38 | Aortic dissection (HP:0002647) | 3.25755607 |
| 39 | Myocardial infarction (HP:0001658) | 3.21924876 |
| 40 | Ketoacidosis (HP:0001993) | 3.10723269 |
| 41 | Conjugated hyperbilirubinemia (HP:0002908) | 3.05624970 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 2.97515616 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95474641 |
| 44 | Vascular tortuosity (HP:0004948) | 2.94111139 |
| 45 | Skin nodule (HP:0200036) | 2.92561068 |
| 46 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.91392692 |
| 47 | Increased connective tissue (HP:0009025) | 2.90466417 |
| 48 | Cerebral aneurysm (HP:0004944) | 2.88087713 |
| 49 | Increased variability in muscle fiber diameter (HP:0003557) | 2.86763798 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.85165782 |
| 51 | Hyperbilirubinemia (HP:0002904) | 2.83881402 |
| 52 | Gout (HP:0001997) | 2.83400859 |
| 53 | Spontaneous abortion (HP:0005268) | 2.78958036 |
| 54 | Arterial tortuosity (HP:0005116) | 2.73772627 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.67986026 |
| 56 | Glomerulonephritis (HP:0000099) | 2.65354041 |
| 57 | Abnormality of serum amino acid levels (HP:0003112) | 2.64547281 |
| 58 | Cervical subluxation (HP:0003308) | 2.62032551 |
| 59 | Steatorrhea (HP:0002570) | 2.61427720 |
| 60 | Asymmetric septal hypertrophy (HP:0001670) | 2.61345789 |
| 61 | Esophageal varix (HP:0002040) | 2.60700221 |
| 62 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.59773999 |
| 63 | Metabolic acidosis (HP:0001942) | 2.52070625 |
| 64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51540980 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.51540980 |
| 66 | Aneurysm (HP:0002617) | 2.51240777 |
| 67 | Vascular calcification (HP:0004934) | 2.50978438 |
| 68 | Spastic diplegia (HP:0001264) | 2.47333831 |
| 69 | Exercise-induced myalgia (HP:0003738) | 2.47179370 |
| 70 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46434328 |
| 71 | Mucopolysacchariduria (HP:0008155) | 2.43414598 |
| 72 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.43414598 |
| 73 | Mitral stenosis (HP:0001718) | 2.42466148 |
| 74 | Vertebral compression fractures (HP:0002953) | 2.41811099 |
| 75 | Cardiovascular calcification (HP:0011915) | 2.40742668 |
| 76 | Spinal rigidity (HP:0003306) | 2.39240408 |
| 77 | Abnormality of proline metabolism (HP:0010907) | 2.38346337 |
| 78 | Hydroxyprolinuria (HP:0003080) | 2.38346337 |
| 79 | Hemorrhage of the eye (HP:0011885) | 2.37452215 |
| 80 | Amyloidosis (HP:0011034) | 2.37397321 |
| 81 | Dilatation of the ascending aorta (HP:0005111) | 2.35483000 |
| 82 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.34812883 |
| 83 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.32055397 |
| 84 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.32055397 |
| 85 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.32055397 |
| 86 | Hypoglycemic seizures (HP:0002173) | 2.30946031 |
| 87 | Hypochromic microcytic anemia (HP:0004840) | 2.26596849 |
| 88 | Abnormal cartilage morphology (HP:0002763) | 2.26463004 |
| 89 | Lethargy (HP:0001254) | 2.26293957 |
| 90 | Abnormal gallbladder morphology (HP:0012437) | 2.24050158 |
| 91 | Ulnar deviation of the wrist (HP:0003049) | 2.23419327 |
| 92 | Cholelithiasis (HP:0001081) | 2.23249463 |
| 93 | Dysostosis multiplex (HP:0000943) | 2.22835793 |
| 94 | Malnutrition (HP:0004395) | 2.22760512 |
| 95 | Nephritis (HP:0000123) | 2.22117604 |
| 96 | Generalized aminoaciduria (HP:0002909) | 2.22018089 |
| 97 | Gingival bleeding (HP:0000225) | 2.21294467 |
| 98 | Hypertriglyceridemia (HP:0002155) | 2.20295598 |
| 99 | Blue sclerae (HP:0000592) | 2.19881755 |
| 100 | Pancreatitis (HP:0001733) | 2.19777961 |
| 101 | Sensorimotor neuropathy (HP:0007141) | 2.17860645 |
| 102 | Mitral valve prolapse (HP:0001634) | 2.17643645 |
| 103 | Cholecystitis (HP:0001082) | 2.17268306 |
| 104 | Abnormal gallbladder physiology (HP:0012438) | 2.17268306 |
| 105 | Broad metatarsal (HP:0001783) | 2.17025445 |
| 106 | Bladder diverticulum (HP:0000015) | 2.16609245 |
| 107 | Late onset (HP:0003584) | 2.16192526 |
| 108 | Neonatal onset (HP:0003623) | 2.15334964 |
| 109 | Eczematoid dermatitis (HP:0000976) | 2.15113982 |
| 110 | Round ear (HP:0100830) | 2.14125658 |
| 111 | Ankle contracture (HP:0006466) | 2.12254047 |
| 112 | Menorrhagia (HP:0000132) | 2.11479132 |
| 113 | Acanthocytosis (HP:0001927) | 2.10112675 |
| 114 | Slender build (HP:0001533) | 2.07244167 |
| 115 | Spondylolisthesis (HP:0003302) | 2.06985586 |
| 116 | Soft skin (HP:0000977) | 2.06267362 |
| 117 | Wormian bones (HP:0002645) | 2.05446804 |
| 118 | Hyperuricemia (HP:0002149) | 2.03802032 |
| 119 | Increased purine levels (HP:0004368) | 2.03802032 |
| 120 | Muscle fiber splitting (HP:0003555) | 2.03750978 |
| 121 | Atrophic scars (HP:0001075) | 2.02317997 |
| 122 | Irritability (HP:0000737) | 2.02203986 |
| 123 | Thrombophlebitis (HP:0004418) | 2.01701665 |
| 124 | Fragile skin (HP:0001030) | 2.01650509 |
| 125 | Joint stiffness (HP:0001387) | 2.01508562 |
| 126 | Obstructive sleep apnea (HP:0002870) | 2.01055193 |
| 127 | Vomiting (HP:0002013) | 1.97515502 |
| 128 | Distal lower limb muscle weakness (HP:0009053) | 1.97078448 |
| 129 | Muscle fiber inclusion bodies (HP:0100299) | 1.96125894 |
| 130 | Enlarged kidneys (HP:0000105) | 1.94915624 |
| 131 | Thin bony cortex (HP:0002753) | 1.94244963 |
| 132 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.93556314 |
| 133 | Spontaneous hematomas (HP:0007420) | 1.93040448 |
| 134 | Shallow orbits (HP:0000586) | 1.92656806 |
| 135 | Nemaline bodies (HP:0003798) | 1.91647972 |
| 136 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.91283412 |
| 137 | Osteolytic defects of the hand bones (HP:0009699) | 1.91283412 |
| 138 | Proximal tubulopathy (HP:0000114) | 1.91144693 |
| 139 | Ovoid vertebral bodies (HP:0003300) | 1.89478880 |
| 140 | Follicular hyperkeratosis (HP:0007502) | 1.88983834 |
| 141 | Abnormality of iron homeostasis (HP:0011031) | 1.88251884 |
| 142 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.87049957 |
| 143 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86638169 |
| 144 | Purpura (HP:0000979) | 1.86510578 |
| 145 | Brushfield spots (HP:0001088) | 1.85358705 |
| 146 | Neonatal short-limb short stature (HP:0008921) | 1.83843060 |
| 147 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83012487 |
| 148 | Abnormality of the gallbladder (HP:0005264) | 1.82816753 |
| 149 | Cerebral edema (HP:0002181) | 1.81005902 |
| 150 | Striae distensae (HP:0001065) | 1.79848811 |
| 151 | Alkalosis (HP:0001948) | 1.79509528 |
| 152 | Emphysema (HP:0002097) | 1.78339901 |
| 153 | Biconcave vertebral bodies (HP:0004586) | 1.78057901 |
| 154 | Joint laxity (HP:0001388) | 1.77884680 |
| 155 | Polycythemia (HP:0001901) | 1.77789223 |
| 156 | Hyporeflexia of lower limbs (HP:0002600) | 1.77740080 |
| 157 | Hyperglycemia (HP:0003074) | 1.77616078 |
| 158 | Opisthotonus (HP:0002179) | 1.77436821 |
| 159 | Abnormality of the Achilles tendon (HP:0005109) | 1.76197417 |
| 160 | Gastrointestinal infarctions (HP:0005244) | 1.73733166 |
| 161 | Rickets (HP:0002748) | 1.73322513 |
| 162 | Abnormal delivery (HP:0001787) | 1.72500846 |
| 163 | Peritonitis (HP:0002586) | 1.72253367 |
| 164 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.70891142 |
| 165 | Broad face (HP:0000283) | 1.67603735 |
| 166 | Distal lower limb amyotrophy (HP:0008944) | 1.67313458 |
| 167 | Gingivitis (HP:0000230) | 1.67189984 |
| 168 | Aortic regurgitation (HP:0001659) | 1.67095642 |
| 169 | Abnormality of glycolipid metabolism (HP:0010969) | 1.66562027 |
| 170 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.66562027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.31480794 |
| 2 | ERN1 | 4.62954017 |
| 3 | SIK1 | 3.91586528 |
| 4 | FGFR4 | 3.74512595 |
| 5 | TRIB3 | 3.71150977 |
| 6 | PKN2 | 2.49334389 |
| 7 | MST1R | 2.34467333 |
| 8 | PRPF4B | 2.32915971 |
| 9 | TAOK3 | 2.31866568 |
| 10 | INSRR | 2.28789090 |
| 11 | CAMK1D | 2.04835540 |
| 12 | LATS1 | 1.96204773 |
| 13 | ERBB4 | 1.94064654 |
| 14 | TGFBR2 | 1.86825231 |
| 15 | PTK6 | 1.75239985 |
| 16 | CDC42BPA | 1.67872105 |
| 17 | FLT3 | 1.67311566 |
| 18 | RIPK1 | 1.64716150 |
| 19 | NEK9 | 1.64598229 |
| 20 | FRK | 1.59355620 |
| 21 | ICK | 1.58614749 |
| 22 | TYK2 | 1.55921824 |
| 23 | MAPK11 | 1.51163794 |
| 24 | OBSCN | 1.45234136 |
| 25 | EPHB1 | 1.41206228 |
| 26 | MAP3K13 | 1.41167070 |
| 27 | PIK3CG | 1.40404946 |
| 28 | FGFR2 | 1.37130482 |
| 29 | BLK | 1.36497240 |
| 30 | TIE1 | 1.34122729 |
| 31 | MAP2K3 | 1.33521154 |
| 32 | TRPM7 | 1.31229109 |
| 33 | CAMK1G | 1.30682436 |
| 34 | JAK1 | 1.23499156 |
| 35 | KDR | 1.20658485 |
| 36 | PRKAA2 | 1.18773852 |
| 37 | PRKD2 | 1.18349853 |
| 38 | MAP3K7 | 1.17771886 |
| 39 | AKT3 | 1.17317571 |
| 40 | PDGFRA | 1.16778059 |
| 41 | TTN | 1.14411847 |
| 42 | MAP3K3 | 1.14227800 |
| 43 | MAP2K4 | 1.12521673 |
| 44 | MAP3K10 | 1.11864022 |
| 45 | MAPK7 | 1.11813674 |
| 46 | MET | 1.10902820 |
| 47 | JAK2 | 1.09663396 |
| 48 | MARK2 | 1.08028589 |
| 49 | SMG1 | 1.05528271 |
| 50 | MAPKAPK3 | 1.04962090 |
| 51 | ABL2 | 1.04353159 |
| 52 | EPHA3 | 1.04089282 |
| 53 | FGFR3 | 1.01832179 |
| 54 | TBK1 | 1.00663725 |
| 55 | CDK6 | 1.00406555 |
| 56 | HIPK2 | 0.92994740 |
| 57 | CDK12 | 0.91443707 |
| 58 | NLK | 0.86991609 |
| 59 | PTK2 | 0.86687048 |
| 60 | MAP3K1 | 0.84521503 |
| 61 | MYLK | 0.82863072 |
| 62 | MOS | 0.82624860 |
| 63 | EPHA2 | 0.81814861 |
| 64 | CSK | 0.81728606 |
| 65 | RPS6KA2 | 0.81164288 |
| 66 | LRRK2 | 0.78483929 |
| 67 | GSK3A | 0.78425620 |
| 68 | STK38 | 0.77711399 |
| 69 | MAP4K1 | 0.74747492 |
| 70 | PDK3 | 0.74557030 |
| 71 | PDK4 | 0.74557030 |
| 72 | IRAK3 | 0.70150608 |
| 73 | STK38L | 0.69502640 |
| 74 | ERBB2 | 0.68605335 |
| 75 | MTOR | 0.67331176 |
| 76 | MAPK4 | 0.66688177 |
| 77 | GRK6 | 0.65787965 |
| 78 | DAPK2 | 0.63539903 |
| 79 | PRKAA1 | 0.60999279 |
| 80 | EPHB2 | 0.60650566 |
| 81 | BMX | 0.60287135 |
| 82 | CSF1R | 0.60005511 |
| 83 | FER | 0.59509841 |
| 84 | SGK3 | 0.59485262 |
| 85 | RPS6KL1 | 0.58338590 |
| 86 | RPS6KC1 | 0.58338590 |
| 87 | PDPK1 | 0.58070089 |
| 88 | MAP2K1 | 0.57972941 |
| 89 | MAPK12 | 0.56585387 |
| 90 | HCK | 0.56281445 |
| 91 | DYRK1B | 0.55966196 |
| 92 | PTK2B | 0.55728000 |
| 93 | PHKG2 | 0.55446709 |
| 94 | PHKG1 | 0.55446709 |
| 95 | ZAP70 | 0.54815703 |
| 96 | KSR2 | 0.54371431 |
| 97 | MELK | 0.54252189 |
| 98 | PRKACG | 0.53205079 |
| 99 | MAP3K14 | 0.52522064 |
| 100 | STK3 | 0.52496510 |
| 101 | RET | 0.51723312 |
| 102 | PRKCZ | 0.49738205 |
| 103 | CHUK | 0.49698629 |
| 104 | RPS6KA6 | 0.49212185 |
| 105 | JAK3 | 0.48363971 |
| 106 | TNK2 | 0.47284592 |
| 107 | IGF1R | 0.46379593 |
| 108 | MAP3K2 | 0.45618693 |
| 109 | FES | 0.45469167 |
| 110 | MAP3K6 | 0.44847839 |
| 111 | PAK2 | 0.44539840 |
| 112 | BTK | 0.43688353 |
| 113 | TAOK2 | 0.42945173 |
| 114 | WNK1 | 0.42616775 |
| 115 | MAP3K11 | 0.42612807 |
| 116 | PIK3CA | 0.41547848 |
| 117 | MAP2K6 | 0.40863080 |
| 118 | IRAK1 | 0.40771353 |
| 119 | SGK2 | 0.40577116 |
| 120 | KIT | 0.40284554 |
| 121 | PAK4 | 0.40074117 |
| 122 | EGFR | 0.39380702 |
| 123 | IKBKE | 0.38364750 |
| 124 | PINK1 | 0.38304842 |
| 125 | PDK2 | 0.37637514 |
| 126 | CDK4 | 0.37592231 |
| 127 | PRKCH | 0.37300789 |
| 128 | WNK4 | 0.37277055 |
| 129 | LMTK2 | 0.37173257 |
| 130 | DDR2 | 0.36001465 |
| 131 | PDGFRB | 0.34552953 |
| 132 | PRKD1 | 0.34029663 |
| 133 | FGFR1 | 0.33996372 |
| 134 | MAP2K2 | 0.32506003 |
| 135 | LATS2 | 0.32437182 |
| 136 | PDK1 | 0.31428843 |
| 137 | MAPK15 | 0.31364907 |
| 138 | CAMK2G | 0.30851472 |
| 139 | ABL1 | 0.30724540 |
| 140 | EEF2K | 0.30399871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.20000759 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.55927519 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15497362 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06693128 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.86067238 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.85497254 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71220518 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65199314 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62835275 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.59672543 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.45248515 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35586847 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.25224302 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.23970204 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18760400 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.10384840 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.06655108 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.05439772 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.96682409 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.93856842 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92793160 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.78628921 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77067209 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.75957347 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73466192 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.71523672 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69253678 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53478698 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.53240568 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53061244 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52045681 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52011218 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51192488 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49957535 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.45998370 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34274292 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.33301418 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32041993 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.25419834 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24549207 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23689608 |
| 42 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.22742051 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20678821 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19869460 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16821065 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13015499 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12238362 |
| 48 | Focal adhesion_Homo sapiens_hsa04510 | 1.05775551 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03027648 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01956856 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93052913 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.92938838 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 0.92356279 |
| 54 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92223346 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90124498 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90067270 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89928122 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88820077 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88736631 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88609224 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88377914 |
| 62 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.88104213 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85052386 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84921128 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84543169 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82012292 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79920153 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76451385 |
| 69 | Leishmaniasis_Homo sapiens_hsa05140 | 0.75143905 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73650150 |
| 71 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72035754 |
| 72 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71642135 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68247973 |
| 74 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68144680 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.64851313 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64685807 |
| 77 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.64385208 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61769359 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58080074 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56273842 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56191814 |
| 82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55488998 |
| 83 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53699818 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53660527 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53127679 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50936008 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.49939250 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.49886091 |
| 89 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.48509289 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.47882875 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.47744646 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47610505 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46567025 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46245261 |
| 95 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45922470 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44306179 |
| 97 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44025932 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43306923 |
| 99 | Allograft rejection_Homo sapiens_hsa05330 | 0.42298968 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.41151428 |
| 101 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40711820 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.40687376 |
| 103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39986692 |
| 104 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.38407767 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38384152 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38100835 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.37666683 |
| 108 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.37487401 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37209797 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37125213 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35625573 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.35427155 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35122201 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34935564 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33016519 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29900780 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.27714979 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27119433 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.20101466 |
| 120 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19337175 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19332635 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14776598 |
| 123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.07851962 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.07818531 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.06291083 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | 0.04914739 |
| 127 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.02297189 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.01184800 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.00406873 |
| 130 | Malaria_Homo sapiens_hsa05144 | -0.1161035 |
| 131 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0990446 |
| 132 | Pertussis_Homo sapiens_hsa05133 | -0.0852773 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0841374 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0821481 |
| 135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0807043 |
| 136 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0790803 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0766870 |
| 138 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0733143 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0694890 |
| 140 | Hepatitis C_Homo sapiens_hsa05160 | -0.0643992 |
| 141 | Bladder cancer_Homo sapiens_hsa05219 | -0.0591113 |
| 142 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0156369 |
| 143 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0093717 |
| 144 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0086605 |

